Page last updated: 2024-08-21

adamantane and Cerebrovascular Disorders

adamantane has been researched along with Cerebrovascular Disorders in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bhatt, DL; Bonaca, MP; Braunwald, E; Gutierrez, JA; Hirshberg, B; Im, K; Mosenzon, O; Raz, I; Scirica, BM; Steg, PG	1
Akopian, AA; Alikhanian, KB; Bagdasarian, NA; Khostikian, NG; Kukhtarova, AM; Meliksetian, VS; Mirzoian, NR; Stepanian, AG	1
Couturier, A; Dejager, S; Foley, JE; Kothny, W; Ligueros-Saylan, M; Schweizer, A	1

Reviews

1 review(s) available for adamantane and Cerebrovascular Disorders

Article	Year
Assessing the cardio-cerebrovascular safety of vildagliptin: meta-analysis of adjudicated events from a large Phase III type 2 diabetes population. Diabetes, obesity & metabolism, 2010, Volume: 12, Issue:6 Topics: Adamantane; Cerebrovascular Disorders; Clinical Trials, Phase III as Topic; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptidyl-Peptidase IV Inhibitors; Female; Humans; Male; Middle Aged; Nitriles; Pyrrolidines; Randomized Controlled Trials as Topic; Vildagliptin	2010

Article

Year

Assessing the cardio-cerebrovascular safety of vildagliptin: meta-analysis of adjudicated events from a large Phase III type 2 diabetes population.

Diabetes, obesity & metabolism, 2010, Volume: 12, Issue:6

Topics: Adamantane; Cerebrovascular Disorders; Clinical Trials, Phase III as Topic; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptidyl-Peptidase IV Inhibitors; Female; Humans; Male; Middle Aged; Nitriles; Pyrrolidines; Randomized Controlled Trials as Topic; Vildagliptin

2010

Trials

1 trial(s) available for adamantane and Cerebrovascular Disorders

Article	Year
Prevalence and Outcomes of Polyvascular (Coronary, Peripheral, or Cerebrovascular) Disease in Patients With Diabetes Mellitus (From the SAVOR-TIMI 53 Trial). The American journal of cardiology, 2019, 01-01, Volume: 123, Issue:1 Topics: Adamantane; Aged; Cerebrovascular Disorders; Coronary Disease; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Prevalence; Risk Factors; Treatment Outcome	2019

Article

Year

Prevalence and Outcomes of Polyvascular (Coronary, Peripheral, or Cerebrovascular) Disease in Patients With Diabetes Mellitus (From the SAVOR-TIMI 53 Trial).

The American journal of cardiology, 2019, 01-01, Volume: 123, Issue:1

Topics: Adamantane; Aged; Cerebrovascular Disorders; Coronary Disease; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Prevalence; Risk Factors; Treatment Outcome

2019

Other Studies

1 other study(ies) available for adamantane and Cerebrovascular Disorders

Article	Year
[The effect of 5-hydroxyadamantan-2-one on morphological status of rats' brain tissues in local permanent ischemia conditions]. Eksperimental'naia i klinicheskaia farmakologiia, 2013, Volume: 76, Issue:6 Topics: Adamantane; Animals; Animals, Outbred Strains; Brain; Brain Ischemia; Cerebrovascular Disorders; Drug Administration Schedule; GABA Agonists; Injections, Intraperitoneal; Male; Protective Agents; Rats	2013

Article

Year

[The effect of 5-hydroxyadamantan-2-one on morphological status of rats' brain tissues in local permanent ischemia conditions].

Eksperimental'naia i klinicheskaia farmakologiia, 2013, Volume: 76, Issue:6

Topics: Adamantane; Animals; Animals, Outbred Strains; Brain; Brain Ischemia; Cerebrovascular Disorders; Drug Administration Schedule; GABA Agonists; Injections, Intraperitoneal; Male; Protective Agents; Rats

2013